Cargando…
Highly elevated serum lactate dehydrogenase is associated with central nervous system relapse in patients with diffuse large B-cell lymphoma: Results of a multicenter prospective cohort study
Central nervous system involvement remains a challenging issue in the treatment of patients with diffuse large B-cell lymphoma. We conducted a prospective cohort study with newly diagnosed diffuse large B-cell lymphoma patients receiving rituximab, cyclophosphamide, doxorubicin, vincristine, and pre...
Autores principales: | Kim, Seok Jin, Hong, Jun Sik, Chang, Myung Hee, Kim, Jeong-A, Kwak, Jae-Yong, Kim, Jin Seok, Yoon, Dok Hyun, Lee, Won Sik, Do, Young Rok, Kang, Hye Jin, Eom, Hyeon-Seok, Park, Yong, Won, Jong-Ho, Mun, Yeung-Chul, Kim, Hyo Jung, Kwon, Jung Hye, Kong, Jee Hyun, Oh, Sung Yong, Lee, Sunah, Bae, Sung Hwa, Yang, Deok-Hwan, Jun, Hyun Jung, Kim, Yang Soo, Yun, Hwan Jung, Il Lee, Soon, Kim, Min Kyoung, Park, Eun Kyung, Kim, Won Seog, Suh, Cheolwon |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5342142/ https://www.ncbi.nlm.nih.gov/pubmed/27713132 http://dx.doi.org/10.18632/oncotarget.12459 |
Ejemplares similares
-
Improved prognostic stratification using NCCN- and GELTAMO-international prognostic index in patients with diffuse large B-cell lymphoma
por: Hong, Junshik, et al.
Publicado: (2017) -
First-Line Treatment for Primary Breast Diffuse Large B-Cell Lymphoma Using Immunochemotherapy and Central Nervous System Prophylaxis: A Multicenter Phase 2 Trial
por: Yhim, Ho-Young, et al.
Publicado: (2020) -
Platelet to lymphocyte ratio (PLR) retains independent prognostic significance in advanced stage marginal zone lymphoma patients treated with rituximab, cyclophosphamide, vincristine, and prednisone combination chemotherapy (R-CVP): Consortium for Improving Survival of Lymphoma trial
por: Seo, Jeongkuk, et al.
Publicado: (2017) -
Outcomes in Refractory Diffuse Large B-Cell Lymphoma: Results from Two Prospective Korean Cohorts
por: Yi, Jun Ho, et al.
Publicado: (2023) -
Plerixafor use for peripheral blood stem cell mobilization in Korea
por: Kim, Seok Jin, et al.
Publicado: (2013)